Silverback Therapeutics Inc (SBTX)

NASDAQ
3.29
-0.07(-2.08%)
  • Volume:
    21,366
  • Day's Range:
    3.29 - 3.36
  • 52 wk Range:
    2.80 - 35.63

SBTX Overview

Prev. Close
3.36
Day's Range
3.29-3.36
Revenue
-
Open
3.36
52 wk Range
2.8-35.63
EPS
-2.72
Volume
21,366
Market Cap
118.09M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
408,441
P/E Ratio
-
Beta
-
1-Year Change
-88.07%
Shares Outstanding
35,145,281
Next Earnings Date
Aug 11, 2022
What is your sentiment on Silverback?
or
Vote to see community's results!

Silverback Therapeutics Inc News

Silverback Therapeutics Inc Company Profile

Silverback Therapeutics Inc Company Profile

Employees
90

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralStrong Sell
Technical IndicatorsBuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyBuyStrong Sell